|
|||||
|
|
| 抗血管生成药物治疗肺癌脑转移的研究新进展 | |
| 引用本文： | 鲍瑜,朱立建(综述),钱江(审校). 抗血管生成药物治疗肺癌脑转移的研究新进展[J]. 实用肿瘤学杂志, 2021, 35(1): 91-96. DOI: 10.11904/j.issn.1002-3070.2021.01.019 |
| 作者姓名： | 鲍瑜 朱立建(综述) 钱江(审校) |
| 作者单位： | 池州市人民医院肿瘤内科,安徽医科大学附属池州医院(池州 247000) |
| 摘 要： | 晚期肺癌脑转移发生率高,预后差.近年来,随着肺癌总体治疗的发展,为晚期肺癌脑转移提供了更多的治疗手段和期待.目前的临床研究提示抗血管生成药物在肺癌脑转移的治疗中占有重要地位,从大分子的单克隆抗体,到泛靶点抗血管药物,再到小分子酪氨酸激酶抑制剂(Tyrosine kinase inhibitor,TKI),均显示出一定的... |
| 关 键 词： | 抗血管生成 肺癌 脑转移 |
New progress in the research of anti-angiogenic drugs in the treatment of lung cancer with brain metastases |
|
| BAO Yu,ZHU Lijian,QIAN Jiang. New progress in the research of anti-angiogenic drugs in the treatment of lung cancer with brain metastases[J]. Journal of Practical Oncology, 2021, 35(1): 91-96. DOI: 10.11904/j.issn.1002-3070.2021.01.019 | |
| Authors: | BAO Yu ZHU Lijian QIAN Jiang |
| Affiliation: | Department of Oncology,People's Hospital of Chizhou,Affiliated Chizhou Hospital of Anhui Medical University,Chizhou 247000,China |
| Abstract: | The incidence of brain metastases in advanced lung cancer is high and the prognosis is poor.In recent years,with the development of overall treatment for lung cancer,more treatments and expectations have been provided for advanced lung cancer with brain metastases.Current clinical studies suggest that antiangiogenic drugs play an important role in the treatment of lung cancer with brain metastasis including from monoclonal antibody to multi-target antiangiogenic drugs and then to small molecule tyrosine kinase inhibitor(TKI).These drugs have shown a certain efficacy and good safety,and they also show a significantly synergistic anti-tumor effect on chemotherapy,radiotherapy and epidermal growth factor receptor TKI(EGFR-TKI).This article reviews the new progress of anti-angiogenic drugs in the treatment of lung cancer with brain metastases. |
| Keywords: | Antiangiogenesis Lung cancer Brain metastases |
| 本文献已被 维普 等数据库收录！ | |
| 点击此处可从《实用肿瘤学杂志》浏览原始摘要信息 | |
| 点击此处可从《实用肿瘤学杂志》下载免费的PDF全文 | |